vs
Axos Financial, Inc.（AX）与MADRIGAL PHARMACEUTICALS, INC.（MDGL）财务数据对比。点击上方公司名可切换其他公司
Axos Financial, Inc.的季度营收约是MADRIGAL PHARMACEUTICALS, INC.的1.2倍（$392.2M vs $321.1M），Axos Financial, Inc.净利率更高（31.8% vs -18.2%，领先50.0%）
Axos Financial是总部位于美国内华达州拉斯维加斯的银行控股公司，旗下拥有直销银行Axos Bank，同时提供注册投资顾问服务及电子交易平台，深耕数字化金融赛道，可为用户提供多元便捷的金融服务解决方案。
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
AX vs MDGL — 直观对比
营收规模更大
AX
是对方的1.2倍
$321.1M
净利率更高
AX
高出50.0%
-18.2%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $392.2M | $321.1M |
| 净利润 | $124.7M | $-58.6M |
| 毛利率 | — | — |
| 营业利润率 | — | -18.6% |
| 净利率 | 31.8% | -18.2% |
| 营收同比 | — | 210.8% |
| 净利润同比 | 18.5% | 1.4% |
| 每股收益（稀释后） | $2.15 | $-2.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXMDGL
| Q1 26 | $392.2M | — | ||
| Q4 25 | $385.1M | $321.1M | ||
| Q3 25 | $323.4M | $287.3M | ||
| Q2 25 | $321.4M | $212.8M | ||
| Q1 25 | $308.8M | $137.3M | ||
| Q4 24 | $307.9M | $103.3M | ||
| Q3 24 | $320.7M | $62.2M | ||
| Q2 24 | $290.9M | — |
净利润AXMDGL
| Q1 26 | $124.7M | — | ||
| Q4 25 | $128.4M | $-58.6M | ||
| Q3 25 | $112.4M | $-114.2M | ||
| Q2 25 | $110.7M | $-42.3M | ||
| Q1 25 | $105.2M | $-73.2M | ||
| Q4 24 | $104.7M | $-59.4M | ||
| Q3 24 | $112.3M | $-107.0M | ||
| Q2 24 | $104.9M | — |
毛利率AXMDGL
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 96.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
营业利润率AXMDGL
| Q1 26 | — | — | ||
| Q4 25 | 45.6% | -18.6% | ||
| Q3 25 | 46.3% | -39.7% | ||
| Q2 25 | 48.5% | -22.2% | ||
| Q1 25 | 47.9% | -57.8% | ||
| Q4 24 | 48.8% | -64.8% | ||
| Q3 24 | 49.6% | -187.1% | ||
| Q2 24 | 49.6% | — |
净利率AXMDGL
| Q1 26 | 31.8% | — | ||
| Q4 25 | 33.3% | -18.2% | ||
| Q3 25 | 34.7% | -39.8% | ||
| Q2 25 | 34.4% | -19.9% | ||
| Q1 25 | 34.1% | -53.4% | ||
| Q4 24 | 34.0% | -57.5% | ||
| Q3 24 | 35.0% | -172.0% | ||
| Q2 24 | 36.0% | — |
每股收益（稀释后）AXMDGL
| Q1 26 | $2.15 | — | ||
| Q4 25 | $2.22 | $-2.55 | ||
| Q3 25 | $1.94 | $-5.08 | ||
| Q2 25 | $1.89 | $-1.90 | ||
| Q1 25 | $1.81 | $-3.32 | ||
| Q4 24 | $1.80 | $-2.50 | ||
| Q3 24 | $1.93 | $-4.92 | ||
| Q2 24 | $1.75 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $198.7M |
| 总债务越低越好 | — | $339.9M |
| 股东权益账面价值 | $3.1B | $602.7M |
| 总资产 | $29.2B | $1.3B |
| 负债/权益比越低杠杆越低 | — | 0.56× |
8季度趋势，按日历期对齐
现金及短期投资AXMDGL
| Q1 26 | — | — | ||
| Q4 25 | $1.0B | $198.7M | ||
| Q3 25 | $2.6B | $295.7M | ||
| Q2 25 | $1.9B | $186.2M | ||
| Q1 25 | $2.0B | $183.6M | ||
| Q4 24 | $2.4B | $100.0M | ||
| Q3 24 | $2.6B | $232.7M | ||
| Q2 24 | $2.0B | — |
总债务AXMDGL
| Q1 26 | — | — | ||
| Q4 25 | — | $339.9M | ||
| Q3 25 | — | $339.8M | ||
| Q2 25 | $312.7M | $118.4M | ||
| Q1 25 | $377.4M | $118.0M | ||
| Q4 24 | $358.7M | $117.6M | ||
| Q3 24 | $313.5M | $117.1M | ||
| Q2 24 | $325.7M | — |
股东权益AXMDGL
| Q1 26 | $3.1B | — | ||
| Q4 25 | $2.9B | $602.7M | ||
| Q3 25 | $2.8B | $625.7M | ||
| Q2 25 | $2.7B | $696.0M | ||
| Q1 25 | $2.6B | $710.6M | ||
| Q4 24 | $2.5B | $754.4M | ||
| Q3 24 | $2.4B | $777.2M | ||
| Q2 24 | $2.3B | — |
总资产AXMDGL
| Q1 26 | $29.2B | — | ||
| Q4 25 | $28.2B | $1.3B | ||
| Q3 25 | $27.4B | $1.4B | ||
| Q2 25 | $24.8B | $1.0B | ||
| Q1 25 | $24.0B | $996.6M | ||
| Q4 24 | $23.7B | $1.0B | ||
| Q3 24 | $23.6B | $1.1B | ||
| Q2 24 | $22.9B | — |
负债/权益比AXMDGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.56× | ||
| Q3 25 | — | 0.54× | ||
| Q2 25 | 0.12× | 0.17× | ||
| Q1 25 | 0.14× | 0.17× | ||
| Q4 24 | 0.14× | 0.16× | ||
| Q3 24 | 0.13× | 0.15× | ||
| Q2 24 | 0.14× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-133.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-133.8M |
| 自由现金流率自由现金流/营收 | — | -41.7% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AXMDGL
| Q1 26 | — | — | ||
| Q4 25 | $104.1M | $-133.5M | ||
| Q3 25 | $118.4M | $79.8M | ||
| Q2 25 | $490.3M | $-47.1M | ||
| Q1 25 | $73.7M | $-88.9M | ||
| Q4 24 | $162.5M | $-104.5M | ||
| Q3 24 | $70.8M | $-67.0M | ||
| Q2 24 | $305.5M | — |
自由现金流AXMDGL
| Q1 26 | — | — | ||
| Q4 25 | $85.4M | $-133.8M | ||
| Q3 25 | $109.3M | $79.0M | ||
| Q2 25 | $436.1M | — | ||
| Q1 25 | $65.1M | — | ||
| Q4 24 | $156.4M | $-104.7M | ||
| Q3 24 | $53.0M | $-67.8M | ||
| Q2 24 | $269.5M | — |
自由现金流率AXMDGL
| Q1 26 | — | — | ||
| Q4 25 | 22.2% | -41.7% | ||
| Q3 25 | 33.8% | 27.5% | ||
| Q2 25 | 135.7% | — | ||
| Q1 25 | 21.1% | — | ||
| Q4 24 | 50.8% | -101.3% | ||
| Q3 24 | 16.5% | -109.0% | ||
| Q2 24 | 92.6% | — |
资本支出强度AXMDGL
| Q1 26 | — | — | ||
| Q4 25 | 4.9% | 0.1% | ||
| Q3 25 | 2.8% | 0.3% | ||
| Q2 25 | 16.9% | 0.0% | ||
| Q1 25 | 2.8% | 0.0% | ||
| Q4 24 | 2.0% | 0.2% | ||
| Q3 24 | 5.5% | 1.3% | ||
| Q2 24 | 12.4% | — |
现金转化率AXMDGL
| Q1 26 | — | — | ||
| Q4 25 | 0.81× | — | ||
| Q3 25 | 1.05× | — | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 0.70× | — | ||
| Q4 24 | 1.55× | — | ||
| Q3 24 | 0.63× | — | ||
| Q2 24 | 2.91× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AX
| Net Interest Income | $306.3M | 78% |
| Noninterest Income | $86.0M | 22% |
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
